Hassan Abdelilah Tafenzi, Youssef AIT Takniouine, Farah Choulli, Ismail Essadi, Rhizlane Belbaraka. "Adjuvant (Ad) and neoadjuvant (NAd) strategies in higher risk hormone receptor–positive (HR+)/HER2-negative (HER2−) early breast cancer (EBC): Moroccan real-world outcomes.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e12735